Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology : Strategic Partnerships that are Transforming the Healthcare Industry
In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized medicine, combination devices and regenerative medicine, have been the beneficiary of research and business collaborations. This research service identifies areas along the product development cycle that can be mined for collaborations, case studies of successful partnerships from the last few years, and various avenues available for stakeholders.
One of the most lucrative revenue streams for companies and research centers is technology licensing. Technology transfer offices (TTOs) in universities are crucial in positioning intellectual property (IP) toward acquisition/licensing or help in spinning-off into startup companies.
Countries such as Israel, South Korea, Singapore, and Australia have demonstrated remarkable commitment toward improving collaboration culture, by sponsoring technology incubators, funding public-private partnerships, and by having a supportive IP and legal framework.
Market leaders in MedTech, Pharma and Biotech are all engaged in collaborative efforts through open innovation programs and pursuing strategic partnerships. Additionally, all major healthcare companies have a venture capital arm that invests in early stage companies
In the next five years, as regenerative medicine and smart drug delivery products get commercialized, TechVision predicts a surge in collaborative efforts. Particularly, drug-device combination products are expected to gain importance in the healthcare industry.
Table Of Contents
Collaboration between Medical Devices, Pharmaceuticals, and BiotechnologyÂ 1 EXECUTIVE SUMMARY
Executive Summary 1. What You Can Expect 2. Research Methodology 3. Research Methodology 4. The Essence of the Research Service 5. Key Findings
2 INDUSTRY OVERVIEW
Industry Overview 1. The Need for Collaboration within Healthcare 2. Sources of Collaboration in the Healthcare Industry 3. Sources of Collaboration in the Healthcare Industry 4. Types of Collaborations
3 A COMPILATION OF NOTABLE COLLABORATIONS
A Compilation of Notable Collaborations 1. Collaboration by Market Segments 2. 1. Next-Generation Stents 3. Notable Industry Collaborations 4. 2. Tissue Engineered Products 5. Notable Industry Collaborations 6. 3. Smart Drug Delivery 7. Notable Industry Collaborations 8. 4. Companion Diagnostics 9. Notable Industry Partnerships
4 DIFFERENT APPROACHES TO COLLABORATION
Different Approaches to Collaboration 1. Collaboration by Market Participants 2. 1. University-Led Collaborations 3. 2. Government-Led Collaborations 4. 3. Industry Collaborations 5. 4. Research Consortia 6. 5. Joint Ventures
5 ASSESSMENT OF INVESTMENT ECOSYSTEM
Assessment of Investment Ecosystem 1. Overview of Investor Networks 2. 1. Government Funding 3. 2. Venture Capital Funding 4. 3. Corporate Venture Capital (CVC) Funding
6 AVENUES OPEN FOR COLLABORATIONS
Avenues Open for Collaborations 1. Open Innovation 2. Call for Partnerships 3. Research Consortia 4. Technologies Available for Licensing 5. Technologies Available for Licensing 6. Technologies Available for Licensing
7 THE LAST WORD
The Last Word 1. Top Innovation Hotspots 2. Top Corporate Investors 3. TechVision Predictions 4. Key Contacts 5. Legal Disclaimer
8 THE FROST and SULLIVAN STORY
The Frost and Sullivan Story 1. The Frost and Sullivan Story 2. Value Proposition: Future of Your Company and Career 3. Global Perspective 4. Industry Convergence 5. 360Âº Research Perspective 6. Implementation Excellence 7. Our Blue Ocean Strategy